Acenocoumarol
Tetracycline may increase the anticoagulant activities of Acenocoumarol.
Acetyl Sulfisoxazole
The metabolism of Tetracycline can be decreased when combined with Acetyl sulfisoxazole.
Acitretin
The risk or severity of adverse effects can be increased when Tetracycline is combined with Acitretin.
Advertisement
Adapalene
The risk or severity of adverse effects can be increased when Tetracycline is combined with Adapalene.
Alitretinoin
The risk or severity of adverse effects can be increased when Tetracycline is combined with Alitretinoin.
Aloglutamol
Aloglutamol can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Advertisement
Aluminum
Aluminium can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aluminum Hydroxide
Aluminum hydroxide can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
aluminum hydroxide, dried (USP)
Aluminum hydroxide can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Advertisement
Aluminum Magnesium Silicate
Almasilate can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Amdinocillin
The therapeutic efficacy of Amdinocillin can be decreased when used in combination with Tetracycline.
Amdinocillin Pivoxil
The therapeutic efficacy of Pivmecillinam can be decreased when used in combination with Tetracycline.
Amiodarone
The metabolism of Tetracycline can be decreased when combined with Amiodarone.
Amoxicillin
The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Tetracycline.
Amoxicillin Anhydrous
The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Tetracycline.
Ampicillin
The therapeutic efficacy of Ampicillin can be decreased when used in combination with Tetracycline.
Ampicillin (anhydrous)
The therapeutic efficacy of Ampicillin can be decreased when used in combination with Tetracycline.
Apalutamide
The serum concentration of Tetracycline can be decreased when it is combined with Apalutamide.
Aprepitant
The serum concentration of Tetracycline can be increased when it is combined with Aprepitant.
Asunaprevir
The serum concentration of Asunaprevir can be increased when it is combined with Tetracycline.
Atazanavir
The metabolism of Tetracycline can be decreased when combined with Atazanavir.
Atomoxetine
The metabolism of Tetracycline can be decreased when combined with Atomoxetine.
Atorvastatin
The risk or severity of adverse effects can be increased when Tetracycline is combined with Atorvastatin.
Atovaquone
The serum concentration of Atovaquone can be decreased when it is combined with Tetracycline.
Atracurium
Tetracycline may increase the neuromuscular blocking activities of Atracurium.
Atracurium Besylate
Tetracycline may increase the neuromuscular blocking activities of Atracurium besylate.
Azidocillin
The therapeutic efficacy of Azidocillin can be decreased when used in combination with Tetracycline.
Azlocillin
The therapeutic efficacy of Azlocillin can be decreased when used in combination with Tetracycline.
Bacampicillin
The therapeutic efficacy of Bacampicillin can be decreased when used in combination with Tetracycline.
BCG Vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Tetracycline.
Benzylpenicilloyl polylysine
The therapeutic efficacy of Benzylpenicilloyl Polylysine can be decreased when used in combination with Tetracycline.
Bexarotene
The risk or severity of adverse effects can be increased when Tetracycline is combined with Bexarotene.
Bismuth Subcitrate
The serum concentration of Tetracycline can be decreased when it is combined with Bismuth Subcitrate.
Bismuth Subnitrate
Bismuth subnitrate can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bismuth Subsalicylate
The serum concentration of Tetracycline can be decreased when it is combined with Bismuth Subsalicylate.
Boceprevir
The metabolism of Tetracycline can be decreased when combined with Boceprevir.
Bortezomib
The metabolism of Tetracycline can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Tetracycline can be decreased when it is combined with Bosentan.
Bosentan Anhydrous
The serum concentration of Tetracycline can be decreased when it is combined with Bosentan.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Tetracycline.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Tetracycline.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Tetracycline.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Tetracycline.
Calcium Acetate
The serum concentration of Tetracycline can be decreased when it is combined with Calcium Acetate.
Calcium Carbonate
Calcium Carbonate can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
CALCIUM CARBONATE, PRECIPITATED
Calcium Carbonate can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Calcium Chloride
The serum concentration of Tetracycline can be decreased when it is combined with Calcium Chloride.
Calcium Chloride Anhydrous
The serum concentration of Tetracycline can be decreased when it is combined with Calcium Chloride.
Calcium Citrate
The serum concentration of Tetracycline can be decreased when it is combined with Calcium Citrate.
Calcium Glubionate
The serum concentration of Tetracycline can be decreased when it is combined with Calcium glubionate.
Calcium gluceptate
The serum concentration of Tetracycline can be decreased when it is combined with Calcium Gluceptate.
Calcium Gluconate
The serum concentration of Tetracycline can be decreased when it is combined with Calcium gluconate.
Calcium Lactate
The serum concentration of Tetracycline can be decreased when it is combined with Calcium lactate.
CALCIUM LEVULINATE
The serum concentration of Tetracycline can be decreased when it is combined with Calcium levulinate.
Carbamazepine
The metabolism of Tetracycline can be increased when combined with Carbamazepine.
Carbenicillin
The therapeutic efficacy of Carbenicillin can be decreased when used in combination with Tetracycline.
Casein Allergenic Extract
The serum concentration of Tetracycline can be decreased when it is combined with Casein.
Ceritinib
The serum concentration of Tetracycline can be increased when it is combined with Ceritinib.
Cerivastatin
The serum concentration of Cerivastatin can be increased when it is combined with Tetracycline.
Cholestyramine Resin
Cholestyramine can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cisatracurium
Tetracycline may increase the neuromuscular blocking activities of Cisatracurium.
Clarithromycin
The metabolism of Tetracycline can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Tetracycline can be decreased when combined with Clemastine.
Clotrimazole
The metabolism of Tetracycline can be decreased when combined with Clotrimazole.
Cloxacillin
The therapeutic efficacy of Cloxacillin can be decreased when used in combination with Tetracycline.
Cobicistat
The metabolism of Tetracycline can be decreased when combined with Cobicistat.
Colesevelam
Colesevelam can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Colestipol
Colestipol can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Tetracycline.
Crizotinib
The metabolism of Tetracycline can be decreased when combined with Crizotinib.
Curcumin
The metabolism of Tetracycline can be decreased when combined with Curcumin.
Cyclacillin
The therapeutic efficacy of Cyclacillin can be decreased when used in combination with Tetracycline.
Cyclosporine
The metabolism of Tetracycline can be decreased when combined with Cyclosporine.
Dabrafenib
The serum concentration of Tetracycline can be decreased when it is combined with Dabrafenib.
Darunavir
The metabolism of Tetracycline can be decreased when combined with Darunavir.
Dasatinib
The serum concentration of Tetracycline can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Tetracycline can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Tetracycline can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Tetracycline can be decreased when combined with Delavirdine.
Dicloxacillin
The therapeutic efficacy of Dicloxacillin can be decreased when used in combination with Tetracycline.
Dicumarol
Tetracycline may increase the anticoagulant activities of Dicoumarol.
Dihydroergocornine
The risk or severity of adverse effects can be increased when Dihydroergocornine is combined with Tetracycline.
Dihydroergocristine
The risk or severity of adverse effects can be increased when Dihydroergocristine is combined with Tetracycline.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Tetracycline.
Diltiazem
The metabolism of Tetracycline can be decreased when combined with Diltiazem.
Doxacurium Chloride
Tetracycline may increase the neuromuscular blocking activities of Doxacurium chloride.
Doxycycline
The metabolism of Tetracycline can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Tetracycline can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Tetracycline can be decreased when combined with Dronedarone.
Enzalutamide
The serum concentration of Tetracycline can be decreased when it is combined with Enzalutamide.
Ergonovine
The risk or severity of adverse effects can be increased when Ergonovine is combined with Tetracycline.
Ergotamine
The risk or severity of adverse effects can be increased when Ergotamine is combined with Tetracycline.
Erythromycin
The metabolism of Tetracycline can be decreased when combined with Erythromycin.
Ferric Carboxymaltose
Tetracycline can cause a decrease in the absorption of Ferric Carboxymaltose resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ferric Pyrophosphate
Tetracycline can cause a decrease in the absorption of Ferric pyrophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Floxacillin
The therapeutic efficacy of Flucloxacillin can be decreased when used in combination with Tetracycline.
Fluconazole
The metabolism of Tetracycline can be decreased when combined with Fluconazole.
Fluindione
Tetracycline may increase the anticoagulant activities of Fluindione.
Fluvastatin
The serum concentration of Fluvastatin can be increased when it is combined with Tetracycline.
Fluvoxamine
The metabolism of Tetracycline can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Tetracycline can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Tetracycline can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The metabolism of Tetracycline can be increased when combined with Fosphenytoin.
Fusidate
The serum concentration of Tetracycline can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Tetracycline can be increased when it is combined with Fusidic Acid.
Gallamine Triethiodide
Tetracycline may increase the neuromuscular blocking activities of Gallamine Triethiodide.
Hydrotalcite
Hydrotalcite can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Hypoxis hemerocallidea root extract
The serum concentration of Tetracycline can be decreased when it is combined with St. John's Wort.
Ibrutinib
The serum concentration of Ibrutinib can be increased when it is combined with Tetracycline.
Idelalisib
The metabolism of Tetracycline can be decreased when combined with Idelalisib.
Imatinib
The metabolism of Tetracycline can be decreased when combined with Imatinib.
Indinavir
The metabolism of Tetracycline can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Tetracycline can be decreased when combined with Indinavir.
Iron
Tetracycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron Carbonyl
Tetracycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron Sucrose
The serum concentration of Tetracycline can be decreased when it is combined with Iron saccharate.
Iron-Dextran Complex
Tetracycline can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Isavuconazole
The serum concentration of Tetracycline can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Tetracycline can be decreased when combined with Isavuconazonium.
Isotretinoin
The risk or severity of adverse effects can be increased when Tetracycline is combined with Isotretinoin.
Isradipine
The metabolism of Tetracycline can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Tetracycline can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Tetracycline can be increased when it is combined with Ivacaftor.
Ketoconazole
The metabolism of Tetracycline can be decreased when combined with Ketoconazole.
Lanthanum Carbonate
The serum concentration of Tetracycline can be decreased when it is combined with Lanthanum carbonate.
Lisuride
The risk or severity of adverse effects can be increased when Lisuride is combined with Tetracycline.
Lopinavir
The metabolism of Tetracycline can be decreased when combined with Lopinavir.
Lovastatin
The serum concentration of Lovastatin can be increased when it is combined with Tetracycline.
Luliconazole
The serum concentration of Tetracycline can be increased when it is combined with Luliconazole.
Lumacaftor
The metabolism of Tetracycline can be increased when combined with Lumacaftor.
Magaldrate
Magaldrate can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Carbonate
Magnesium carbonate can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Hydroxide
Magnesium hydroxide can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Oxide
Magnesium oxide can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Salicylate
Magnesium salicylate can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium silicate
Magnesium silicate can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Sulfate
Magnesium sulfate can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
MAGNESIUM SULFATE ANHYDROUS
Magnesium sulfate can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Trisilicate
Magnesium Trisilicate can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Mecamylamine
Tetracycline may increase the neuromuscular blocking activities of Mecamylamine.
Medrogestone
The serum concentration of Medrogestone can be decreased when it is combined with Tetracycline.
Metergoline
The risk or severity of adverse effects can be increased when Metergoline is combined with Tetracycline.
Methampicillin
The therapeutic efficacy of Metampicillin can be decreased when used in combination with Tetracycline.
Methylergonovine
The risk or severity of adverse effects can be increased when Methylergometrine is combined with Tetracycline.
Methysergide
The risk or severity of adverse effects can be increased when Methysergide is combined with Tetracycline.
Metocurine
Tetracycline may increase the neuromuscular blocking activities of Metocurine.
Metocurine iodide
Tetracycline may increase the neuromuscular blocking activities of Metocurine Iodide.
Mezlocillin
The therapeutic efficacy of Mezlocillin can be decreased when used in combination with Tetracycline.
Mifepristone
The serum concentration of Tetracycline can be increased when it is combined with Mifepristone.
Mipomersen
Tetracycline may increase the hepatotoxic activities of Mipomersen.
Mitotane
The serum concentration of Tetracycline can be decreased when it is combined with Mitotane.
Mivacurium
Tetracycline may increase the neuromuscular blocking activities of Mivacurium.
Nafcillin
The therapeutic efficacy of Nafcillin can be decreased when used in combination with Tetracycline.
Nefazodone
The metabolism of Tetracycline can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Tetracycline can be decreased when combined with Nelfinavir.
Netupitant
The serum concentration of Tetracycline can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Tetracycline can be increased when combined with Nevirapine.
Nicergoline
The risk or severity of adverse effects can be increased when Nicergoline is combined with Tetracycline.
Nilotinib
The metabolism of Tetracycline can be decreased when combined with Nilotinib.
Olaparib
The metabolism of Tetracycline can be decreased when combined with Olaparib.
Osimertinib
The serum concentration of Tetracycline can be increased when it is combined with Osimertinib.
Oxacillin
The therapeutic efficacy of Oxacillin can be decreased when used in combination with Tetracycline.
Palbociclib
The serum concentration of Tetracycline can be increased when it is combined with Palbociclib.
Pancuronium
Tetracycline may increase the neuromuscular blocking activities of Pancuronium.
Pancuronium Bromide
Tetracycline may increase the neuromuscular blocking activities of Pancuronium.
Penicillin G
The therapeutic efficacy of Benzylpenicillin can be decreased when used in combination with Tetracycline.
penicillin G benzathine
The therapeutic efficacy of Benzathine benzylpenicillin can be decreased when used in combination with Tetracycline.
penicillin G procaine
The therapeutic efficacy of Procaine benzylpenicillin can be decreased when used in combination with Tetracycline.
Penicillin V
The therapeutic efficacy of Phenoxymethylpenicillin can be decreased when used in combination with Tetracycline.
Pentobarbital
The metabolism of Tetracycline can be increased when combined with Pentobarbital.
Pergolide
The risk or severity of adverse effects can be increased when Pergolide is combined with Tetracycline.
Phenindione
Tetracycline may increase the anticoagulant activities of Phenindione.
Phenobarbital
The metabolism of Tetracycline can be increased when combined with Phenobarbital.
Phenprocoumon
Tetracycline may increase the anticoagulant activities of Phenprocoumon.
Phenytoin
The metabolism of Tetracycline can be increased when combined with Phenytoin.
Picosulfuric Acid
The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Tetracycline.
Pipecuronium
Tetracycline may increase the neuromuscular blocking activities of Pipecuronium.
Piperacillin
The therapeutic efficacy of Piperacillin can be decreased when used in combination with Tetracycline.
Piperacillin Anhydrous
The therapeutic efficacy of Piperacillin can be decreased when used in combination with Tetracycline.
Pitavastatin
The serum concentration of Pitavastatin can be increased when it is combined with Tetracycline.
Pivampicillin
The therapeutic efficacy of Pivampicillin can be decreased when used in combination with Tetracycline.
Posaconazole
The metabolism of Tetracycline can be decreased when combined with Posaconazole.
Pravastatin
The serum concentration of Pravastatin can be increased when it is combined with Tetracycline.
Primidone
The metabolism of Tetracycline can be increased when combined with Primidone.
Procaine
The therapeutic efficacy of Procaine can be decreased when used in combination with Tetracycline.
Propicillin
The therapeutic efficacy of Propicillin can be decreased when used in combination with Tetracycline.
Pyrantel
Tetracycline may increase the neuromuscular blocking activities of Pyrantel.
Quinapril
Quinapril can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quinine
The serum concentration of Quinine can be increased when it is combined with Tetracycline.
Ranolazine
The metabolism of Tetracycline can be decreased when combined with Ranolazine.
Rapacuronium
Tetracycline may increase the neuromuscular blocking activities of Rapacuronium.
Rifabutin
The metabolism of Tetracycline can be increased when combined with Rifabutin.
Rifampin
The metabolism of Tetracycline can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Tetracycline can be increased when combined with Rifapentine.
Rilpivirine
The serum concentration of Rilpivirine can be increased when it is combined with Tetracycline.
Rocuronium
Tetracycline may increase the neuromuscular blocking activities of Rocuronium.
Rosuvastatin
The serum concentration of Rosuvastatin can be increased when it is combined with Tetracycline.
Rucaparib
The metabolism of Tetracycline can be decreased when combined with Rucaparib.
Saquinavir
The metabolism of Tetracycline can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Tetracycline can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Tetracycline can be decreased when used in combination with Sarilumab.
Sildenafil
The metabolism of Tetracycline can be decreased when combined with Sildenafil.
Siltuximab
The serum concentration of Tetracycline can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Tetracycline can be increased when it is combined with Simeprevir.
Simvastatin
The serum concentration of Simvastatin can be increased when it is combined with Tetracycline.
Sodium Bicarbonate
Sodium bicarbonate can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
ST. JOHN'S WORT EXTRACT
The serum concentration of Tetracycline can be decreased when it is combined with St. John's Wort.
Succinylcholine
Tetracycline may increase the neuromuscular blocking activities of Succinylcholine.
Sucralfate
Sucralfate can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sucroferric Oxyhydroxide
The serum concentration of Tetracycline can be decreased when it is combined with Iron saccharate.
Sulfisoxazole
The metabolism of Tetracycline can be decreased when combined with Sulfisoxazole.
Telaprevir
The metabolism of Tetracycline can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Tetracycline can be decreased when combined with Telithromycin.
Ticarcillin
The therapeutic efficacy of Ticarcillin can be decreased when used in combination with Tetracycline.
Ticlopidine
The metabolism of Tetracycline can be decreased when combined with Ticlopidine.
Tocilizumab
The serum concentration of Tetracycline can be decreased when it is combined with Tocilizumab.
Tolvaptan
The serum concentration of Tolvaptan can be increased when it is combined with Tetracycline.
Tretinoin
The risk or severity of adverse effects can be increased when Tetracycline is combined with Tretinoin.
Tricalcium Phosphate
The serum concentration of Tetracycline can be decreased when it is combined with Calcium Phosphate.
Tromethamine
Tromethamine can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tubocurarine
Tetracycline may increase the neuromuscular blocking activities of Tubocurarine.
Vecuronium
Tetracycline may increase the neuromuscular blocking activities of Vecuronium.
Vemurafenib
The serum concentration of Tetracycline can be decreased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Tetracycline can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Tetracycline can be decreased when combined with Verapamil.
Voriconazole
The metabolism of Tetracycline can be decreased when combined with Voriconazole.
Warfarin
Tetracycline may increase the anticoagulant activities of Warfarin.
Ziprasidone
The metabolism of Tetracycline can be decreased when combined with Ziprasidone.
